Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diagnostic Imaging

  Free Subscription


Articles published in Am Heart J

Retrieve available abstracts of 87 articles:
HTML format
Text format



Single Articles


    August 2018
  1. DINOV B, Oebel S, Hilbert S, Loebe S, et al
    Characteristics of the ablation lesions in cardiac magnetic resonance imaging after radiofrequency ablation of ventricular arrhythmias in relation to the procedural success.
    Am Heart J. 2018;204:68-75.
    PubMed     Text format     Abstract available


    July 2018
  2. FEYZ L, El Faquir N, Lemmert ME, Misier KR, et al
    Prevalence and consequences of noncardiac incidental findings on preprocedural imaging in the workup for transcatheter aortic valve implantation, renal sympathetic denervation, or MitraClip implantation.
    Am Heart J. 2018;204:83-91.
    PubMed     Text format     Abstract available


    June 2018
  3. MOUSSA PACHA H, Alahdab F, Al-Khadra Y, Idris A, et al
    Ultrasound-guided versus palpation-guided radial artery catheterization in adult population: A systematic review and meta-analysis of randomized controlled trials.
    Am Heart J. 2018;204:1-8.
    PubMed     Text format     Abstract available


  4. ELFWEN L, Lagedal R, James S, Jonsson M, et al
    Coronary angiography in out-of-hospital cardiac arrest without ST elevation on ECG-Short- and long-term survival.
    Am Heart J. 2018;200:90-95.
    PubMed     Text format     Abstract available


  5. LATTUCA B, Barber-Chamoux N, Alos B, Sfaxi A, et al
    Impact of video on the understanding and satisfaction of patients receiving informed consent before elective inpatient coronary angiography: A randomized trial.
    Am Heart J. 2018;200:67-74.
    PubMed     Text format     Abstract available


    May 2018
  6. CASTEL AL, Toledano M, Tribouilloy C, Delelis F, et al
    Assessment of left ventricular size and function by 3-dimensional transthoracic echocardiography: Impact of the echocardiography platform and analysis software.
    Am Heart J. 2018;202:127-136.
    PubMed     Text format     Abstract available


  7. KANG J, Koo BK, Hu X, Lee JM, et al
    Comparison of Fractional FLow Reserve And Intravascular ultrasound-guided Intervention Strategy for Clinical OUtcomes in Patients with InteRmediate Stenosis (FLAVOUR): Rationale and design of a randomized clinical trial.
    Am Heart J. 2018;199:7-12.
    PubMed     Text format     Abstract available


    April 2018
  8. MUHLESTEIN JB, May HT, Galenko O, Knowlton KU, et al
    GlycA and hsCRP are independent and additive predictors of future cardiovascular events among patients undergoing angiography: The intermountain heart collaborative study.
    Am Heart J. 2018;202:27-32.
    PubMed     Text format     Abstract available


  9. BATCHELOR W, Dahya V, McGee D, Katopodis J, et al
    Ultrahigh-resolution ultrasound characterization of access site trauma and intimal hyperplasia following use of a 7F sheathless guide versus 6F sheath/guide combination for transradial artery PCI: Results of the PRAGMATIC trial.
    Am Heart J. 2018;198:75-83.
    PubMed     Text format     Abstract available


    March 2018
  10. LAGEDAL R, Elfwen L, James S, Oldgren J, et al
    Design of DISCO-Direct or Subacute Coronary Angiography in Out-of-Hospital Cardiac Arrest study.
    Am Heart J. 2018;197:53-61.
    PubMed     Text format     Abstract available


    February 2018
  11. GIBBONS RJ, Carryer D, Liu H, Brady PA, et al
    Use of echocardiography in outpatients with chest pain and normal resting electrocardiograms referred to Mayo Clinic Rochester.
    Am Heart J. 2018;196:49-55.
    PubMed     Text format     Abstract available


  12. EGBE A, Khan AR, Miranda WR, Ammash NM, et al
    Mechanism for temporal changes in exercise capacity after Fontan palliation: Role of Doppler echocardiography.
    Am Heart J. 2018;196:144-152.
    PubMed     Text format     Abstract available


    January 2018
  13. EGBE A, Khan AR, Khan SF, Anavekar NS, et al
    Role of Doppler echocardiography for cardiac output assessment in Fontan patients.
    Am Heart J. 2018;195:91-98.
    PubMed     Text format     Abstract available


  14. VEMULAPALLI S, Holmes DR Jr, Dai D, Matsouaka R, et al
    Valve hemodynamic deterioration and cardiovascular outcomes in TAVR: A report from the STS/ACC TVT Registry.
    Am Heart J. 2018;195:1-13.
    PubMed     Text format     Abstract available


  15. MAURI L, Kario K, Basile J, Daemen J, et al
    A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.
    Am Heart J. 2018;195:115-129.
    PubMed     Text format     Abstract available


    December 2017
  16. ILIESCU CA, Cilingiroglu M, Giza DE, Rosales O, et al
    "Bringing on the light" in a complex clinical scenario: Optical coherence tomography-guided discontinuation of antiplatelet therapy in cancer patients with coronary artery disease (PROTECT-OCT registry).
    Am Heart J. 2017;194:83-91.
    PubMed     Text format     Abstract available


  17. LEE S, Kang DH, Kim DH, Song JM, et al
    Late outcome of percutaneous mitral commissurotomy: Randomized comparison of Inoue versus double-balloon technique.
    Am Heart J. 2017;194:1-8.
    PubMed     Text format     Abstract available


    November 2017
  18. LEE PH, Lee JY, Lee CW, Han S, et al
    Long-term outcomes of bypass grafting versus drug-eluting stenting for left main coronary artery disease: Results from the IRIS-MAIN registry.
    Am Heart J. 2017;193:76-83.
    PubMed     Text format     Abstract available


  19. DOROS G, Massaro JM, Kandzari DE, Waksman R, et al
    Rationale of a novel study design for the BIOFLOW V study, a prospective, randomized multicenter study to assess the safety and efficacy of the Orsiro sirolimus-eluting coronary stent system using a Bayesian approach.
    Am Heart J. 2017;193:35-45.
    PubMed     Text format     Abstract available


    October 2017
  20. WAKSMAN R, Torguson R, Spad MA, Garcia-Garcia H, et al
    The Lipid-Rich Plaque Study of vulnerable plaques and vulnerable patients: Study design and rationale.
    Am Heart J. 2017;192:98-104.
    PubMed     Text format     Abstract available


  21. O'BYRNE ML, Shinohara RT, Grant EK, Kanter JP, et al
    Increasing propensity to pursue operative closure of atrial septal defects following changes in the instructions for use of the Amplatzer Septal Occluder device: An observational study using data from the Pediatric Health Information Systems database.
    Am Heart J. 2017;192:85-97.
    PubMed     Text format     Abstract available


  22. KAUSHAL S, Wehman B, Pietris N, Naughton C, et al
    Study design and rationale for ELPIS: A phase I/IIb randomized pilot study of allogeneic human mesenchymal stem cell injection in patients with hypoplastic left heart syndrome.
    Am Heart J. 2017;192:48-56.
    PubMed     Text format     Abstract available


  23. JESSEE R, Peart E, Beineke P, Rosenberg S, et al
    Rheumatoid arthritis complicates noninvasive whole blood gene expression testing for coronary artery disease.
    Am Heart J. 2017;192:13-18.
    PubMed     Text format     Abstract available


  24. ADIR Y, Guazzi M, Offer A, Temporelli PL, et al
    Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities.
    Am Heart J. 2017;192:120-127.
    PubMed     Text format     Abstract available


    September 2017
  25. GUDNADOTTIR GS, Andersen K, Thrainsdottir IS, James SK, et al
    Gender differences in coronary angiography, subsequent interventions, and outcomes among patients with acute coronary syndromes.
    Am Heart J. 2017;191:65-74.
    PubMed     Text format     Abstract available


  26. AMELOOT K, De Deyne C, Ferdinande B, Dupont M, et al
    Mean arterial pressure of 65 mm Hg versus 85-100 mm Hg in comatose survivors after cardiac arrest: Rationale and study design of the Neuroprotect post-cardiac arrest trial.
    Am Heart J. 2017;191:91-98.
    PubMed     Text format     Abstract available


  27. HAYER MK, Edwards NC, Slinn G, Moody WE, et al
    A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial.
    Am Heart J. 2017;191:37-46.
    PubMed     Text format     Abstract available


    August 2017
  28. AUSTIN CO, Landolfo K, Parikh PP, Patel PC, et al
    Retained cardiac implantable electronic device fragments are not associated with magnetic resonance imaging safety issues, morbidity, or mortality after orthotopic heart transplant.
    Am Heart J. 2017;190:46-53.
    PubMed     Text format     Abstract available


  29. SARA JDS, Prasad M, Zhang M, Lennon RJ, et al
    High-sensitivity C-reactive protein is an independent marker of abnormal coronary vasoreactivity in patients with non-obstructive coronary artery disease.
    Am Heart J. 2017;190:1-11.
    PubMed     Text format     Abstract available


    July 2017
  30. AUSTIN C, Burger C, Kane G, Safford R, et al
    High-risk echocardiographic features predict mortality in pulmonary arterial hypertension.
    Am Heart J. 2017;189:167-176.
    PubMed     Text format     Abstract available


  31. SATO K, Grant ADM, Negishi K, Cremer PC, et al
    Reliability of updated left ventricular diastolic function recommendations in predicting elevated left ventricular filling pressure and prognosis.
    Am Heart J. 2017;189:28-39.
    PubMed     Text format     Abstract available


    June 2017
  32. JOHANSEN ND, Biering-Sorensen T, Jensen JS, Mogelvang R, et al
    Diastolic dysfunction revisited: A new, feasible, and unambiguous echocardiographic classification predicts major cardiovascular events.
    Am Heart J. 2017;188:136-146.
    PubMed     Text format     Abstract available


  33. HASAN BS, Lunze FI, Alvi N, Shafer KM, et al
    Feasibility of exercise stress echocardiography and myocardial response in patients with repaired congenital heart disease.
    Am Heart J. 2017;188:1-10.
    PubMed     Text format     Abstract available


  34. GOLDBERG DJ, Zak V, Goldstein BH, Chen S, et al
    Results of a phase I/II multi-center investigation of udenafil in adolescents after fontan palliation.
    Am Heart J. 2017;188:42-52.
    PubMed     Text format     Abstract available


  35. MOGENSEN UM, Kober L, Kristensen SL, Jhund PS, et al
    The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF.
    Am Heart J. 2017;188:35-41.
    PubMed     Text format     Abstract available


  36. GOLDBERG SL, Meredith I, Marwick T, Haluska BA, et al
    A randomized double-blind trial of an interventional device treatment of functional mitral regurgitation in patients with symptomatic congestive heart failure-Trial design of the REDUCE FMR study.
    Am Heart J. 2017;188:167-174.
    PubMed     Text format     Abstract available


  37. ABNOUSI F, Sundaram V, Yong CM, Prats J, et al
    Cangrelor reduces the risk of ischemic complications in patients with single-vessel and multi-vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trial.
    Am Heart J. 2017;188:147-155.
    PubMed     Text format     Abstract available


  38. MELINA G, Angeloni E, Refice S, Monti F, et al
    Clinical SYNTAX score predicts outcomes of patients undergoing coronary artery bypass grafting.
    Am Heart J. 2017;188:118-126.
    PubMed     Text format     Abstract available


    May 2017
  39. FINESCHI M, Verna E, Mezzapelle G, Bartolini D, et al
    Assessing MICRO-vascular resistances via IMR to predict outcome in STEMI patients with multivessel disease undergoing primary PCI (AMICRO): Rationale and design of a prospective multicenter clinical trial.
    Am Heart J. 2017;187:37-44.
    PubMed     Text format     Abstract available


  40. KONG DF, Saito S, Nakamura S, Mehran R, et al
    Rationale and design of the Japan-USA harmonized assessment by randomized, multicenter study of OrbusNEich's combo StEnt (Japan-USA HARMONEE): Assessment of a novel DES platform for percutaneous coronary revascularization in patients with ischemic cor
    Am Heart J. 2017;187:112-121.
    PubMed     Text format     Abstract available


  41. LEMMERT ME, Oldroyd K, Barragan P, Lesiak M, et al
    Reduced duration of dual antiplatelet therapy using an improved drug-eluting stent for percutaneous coronary intervention of the left main artery in a real-world, all-comer population: Rationale and study design of the prospective randomized multicent
    Am Heart J. 2017;187:104-111.
    PubMed     Text format     Abstract available


  42. SCIAHBASI A, Rigattieri S, Sarandrea A, Cera M, et al
    Determinants of operator radiation exposure during percutaneous coronary procedures.
    Am Heart J. 2017;187:10-18.
    PubMed     Text format     Abstract available


    April 2017
  43. ENGBERS EM, Timmer JR, Mouden M, Knollema S, et al
    Changes in cardiovascular medication after coronary artery calcium scanning and normal single photon emission computed tomography myocardial perfusion imaging in symptomatic patients.
    Am Heart J. 2017;186:56-62.
    PubMed     Text format     Abstract available


  44. LEE SE, Lin FY, Lu Y, Chang HJ, et al
    Rationale and design of the Coronary Computed Tomographic Angiography for Selective Cardiac Catheterization: Relation to Cardiovascular Outcomes, Cost Effectiveness and Quality of Life (CONSERVE) trial.
    Am Heart J. 2017;186:48-55.
    PubMed     Text format     Abstract available


    March 2017
  45. BAVISHI C, Sardar P, Chatterjee S, Khan AR, et al
    Intravascular ultrasound-guided vs angiography-guided drug-eluting stent implantation in complex coronary lesions: Meta-analysis of randomized trials.
    Am Heart J. 2017;185:26-34.
    PubMed     Text format     Abstract available


  46. NAKANISHI K, Jin Z, Homma S, Elkind MS, et al
    Left ventricular mass-geometry and silent cerebrovascular disease: The Cardiovascular Abnormalities and Brain Lesions (CABL) study.
    Am Heart J. 2017;185:85-92.
    PubMed     Text format     Abstract available


  47. RICCI F, Mele D, Bianco F, Bucciarelli V, et al
    Right heart-pulmonary circulation unit and cardiac resynchronization therapy.
    Am Heart J. 2017;185:1-16.
    PubMed     Text format     Abstract available


    February 2017
  48. VOORA D, Coles A, Lee KL, Hoffmann U, et al
    An age- and sex-specific gene expression score is associated with revascularization and coronary artery disease: Insights from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial.
    Am Heart J. 2017;184:133-140.
    PubMed     Text format     Abstract available


  49. KOIFMAN E, Didier R, Patel N, Jerusalem Z, et al
    Impact of right ventricular function on outcome of severe aortic stenosis patients undergoing transcatheter aortic valve replacement.
    Am Heart J. 2017;184:141-147.
    PubMed     Text format     Abstract available


  50. NEWMAN JD, Rockman CB, Kosiborod M, Guo Y, et al
    Diabetes mellitus is a coronary heart disease risk equivalent for peripheral vascular disease.
    Am Heart J. 2017;184:114-120.
    PubMed     Text format     Abstract available


  51. SORENSEN LL, Liang HY, Pinheiro A, Hilser A, et al
    Safety profile and utility of treadmill exercise in patients with high-gradient hypertrophic cardiomyopathy.
    Am Heart J. 2017;184:47-54.
    PubMed     Text format     Abstract available


  52. SENTHONG V, Wu Y, Hazen SL, Tang WH, et al
    Predicting long-term prognosis in stable peripheral artery disease with baseline functional capacity estimated by the Duke Activity Status Index.
    Am Heart J. 2017;184:17-25.
    PubMed     Text format     Abstract available


    January 2017
  53. VENKATESH BA, Nauffal V, Noda C, Fujii T, et al
    Baseline assessment and comparison of arterial anatomy, hyperemic flow, and skeletal muscle perfusion in peripheral artery disease: The Cardiovascular Cell Therapy Research Network "Patients with Intermittent Claudication Injected with ALDH Bright Cel
    Am Heart J. 2017;183:24-34.
    PubMed     Text format     Abstract available


    December 2016
  54. LEE SE, Chang HJ, Rizvi A, Hadamitzky M, et al
    Rationale and design of the Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography IMaging (PARADIGM) registry: A comprehensive exploration of plaque progression and its impact on clinical outcomes from a multicenter seri
    Am Heart J. 2016;182:72-79.
    PubMed     Text format     Abstract available


  55. DAHYA V, Xiao J, Prado CM, Burroughs P, et al
    Computed tomography-derived skeletal muscle index: A novel predictor of frailty and hospital length of stay after transcatheter aortic valve replacement.
    Am Heart J. 2016;182:21-27.
    PubMed     Text format     Abstract available


  56. SPITZER E, Van Mieghem NM, Pibarot P, Hahn RT, et al
    Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trial.
    Am Heart J. 2016;182:80-88.
    PubMed     Text format     Abstract available


  57. HARRISON RW, Radhakrishnan V, Lam PS, Allocco DJ, et al
    Rationale and design of the East-West late lumen loss study: Comparison of late lumen loss between Eastern and Western drug-eluting stent study cohorts.
    Am Heart J. 2016;182:103-110.
    PubMed     Text format     Abstract available


    November 2016
  58. VEROUHIS D, Sorensson P, Gourine A, Henareh L, et al
    Effect of remote ischemic conditioning on infarct size in patients with anterior ST-elevation myocardial infarction.
    Am Heart J. 2016;181:66-73.
    PubMed     Text format     Abstract available


  59. PICCARO DE OLIVEIRA P, Gonzales V, Lopes RD, Schmidt MM, et al
    Serious infections among unselected patients with ST-elevation myocardial infarction treated with contemporary primary percutaneous coronary intervention.
    Am Heart J. 2016;181:52-59.
    PubMed     Text format     Abstract available


    October 2016
  60. AGARWAL SK, Kasula S, Almomani A, Hacioglu Y, et al
    Clinical and angiographic predictors of persistently ischemic fractional flow reserve after percutaneous revascularization.
    Am Heart J. 2016;184:10-16.
    PubMed     Text format     Abstract available


  61. SHAH R, Yow E, Jones WS, Kohl LP 3rd, et al
    Comparison of visual assessment of coronary stenosis with independent quantitative coronary angiography: Findings from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial.
    Am Heart J. 2016;184:1-9.
    PubMed     Text format     Abstract available


  62. SUMMERS MR, Menon V
    Insights from cardiac imaging after ST-elevation myocardial infarction: Will increased recognition of patients at risk translate into improved long-term outcomes?
    Am Heart J. 2016;180:113-6.
    PubMed     Text format    


  63. LEMKES JS, Janssens GN, Straaten HM, Elbers PW, et al
    Coronary angiography after cardiac arrest: Rationale and design of the COACT trial.
    Am Heart J. 2016;180:39-45.
    PubMed     Text format     Abstract available


  64. LI Z, Hou Z, Yin W, Liu K, et al
    Effects of statin therapy on progression of mild noncalcified coronary plaque assessed by serial coronary computed tomography angiography: A multicenter prospective study.
    Am Heart J. 2016;180:29-38.
    PubMed     Text format     Abstract available


    September 2016
  65. SORGAARD M, Linde JJ, Hove JD, Petersen JR, et al
    Myocardial perfusion 320-row multidetector computed tomography-guided treatment strategy for the clinical management of patients with recent acute-onset chest pain: Design of the CArdiac cT in the treatment of acute CHest pain (CATCH)-2 randomized con
    Am Heart J. 2016;179:127-35.
    PubMed     Text format     Abstract available


    August 2016
  66. MALEBRANCHE R, Tabou Moyo C, Morisset PH, Raphael NA, et al
    Clinical and echocardiographic characteristics and outcomes in congestive heart failure at the Hospital of The State University of Haiti.
    Am Heart J. 2016;178:151-60.
    PubMed     Text format     Abstract available


  67. O'DONNELL MJ, Eikelboom JW, Yusuf S, Diener HC, et al
    Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study.
    Am Heart J. 2016;178:145-50.
    PubMed     Text format     Abstract available


    July 2016
  68. SMULDERS MW, Kietselaer BL, Schalla S, Bucerius J, et al
    Acute chest pain in the high-sensitivity cardiac troponin era: A changing role for noninvasive imaging?
    Am Heart J. 2016;177:102-11.
    PubMed     Text format     Abstract available


    June 2016
  69. JOUNI H, Askew JW, Crusan DJ, Miller TD, et al
    Temporal trends of single-photon emission computed tomography myocardial perfusion imaging in patients without prior coronary artery disease: A 22-year experience at a tertiary academic medical center.
    Am Heart J. 2016;176:127-33.
    PubMed     Text format     Abstract available


  70. LEHMAN EP, Douglas PS
    The "rise of the rule out": The SPECTer of cardiac stress imaging.
    Am Heart J. 2016;176:122-4.
    PubMed     Text format    


  71. PURI R, Nissen SE, Somaratne R, Cho L, et al
    Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV).
    Am Heart J. 2016;176:83-92.
    PubMed     Text format     Abstract available


    May 2016
  72. ARBEL Y, Qiu F, Bennell MC, Austin PC, et al
    Association between publication of appropriate use criteria and the temporal trends in diagnostic angiography in stable coronary artery disease: A population-based study.
    Am Heart J. 2016;175:153-9.
    PubMed     Text format     Abstract available


  73. DOBSON LE, Fairbairn TA, Musa TA, Uddin A, et al
    Sex-related differences in left ventricular remodeling in severe aortic stenosis and reverse remodeling after aortic valve replacement: A cardiovascular magnetic resonance study.
    Am Heart J. 2016;175:101-11.
    PubMed     Text format     Abstract available


    April 2016
  74. SHAFIQ A, Brawner CA, Aldred HA, Lewis B, et al
    Prognostic value of cardiopulmonary exercise testing in heart failure with preserved ejection fraction. The Henry Ford HospITal CardioPulmonary EXercise Testing (FIT-CPX) project.
    Am Heart J. 2016;174:167-72.
    PubMed     Text format     Abstract available


  75. BANOVIC M, Iung B, Bartunek J, Asanin M, et al
    Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trial.
    Am Heart J. 2016;174:147-53.
    PubMed     Text format     Abstract available


  76. MARMA AK, Opotowsky AR, Fromm BS, Ubeda-Tikkanen A, et al
    Noninvasive cardiac output estimation by inert gas rebreathing in pediatric and congenital heart disease.
    Am Heart J. 2016;174:80-8.
    PubMed     Text format     Abstract available


  77. RAMADAN R, Dhawan SS, Binongo JN, Alkhoder A, et al
    Effect of Angiotensin II Type I Receptor Blockade with Valsartan on Carotid Artery Atherosclerosis: A Double Blind Randomized Clinical Trial Comparing Valsartan and Placebo (EFFERVESCENT).
    Am Heart J. 2016;174:68-79.
    PubMed     Text format     Abstract available


  78. KOHL LP, Leimberger JD, Chiswell K, Jones WS, et al
    Clinical characteristics and outcomes after unplanned intraaortic balloon counterpulsation in the Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction trial.
    Am Heart J. 2016;174:7-13.
    PubMed     Text format     Abstract available


    March 2016
  79. LU J, Bagai A, Buller C, Cheema A, et al
    Incidence and characteristics of inappropriate and false-positive cardiac catheterization laboratory activations in a regional primary percutaneous coronary intervention program.
    Am Heart J. 2016;173:126-33.
    PubMed     Text format     Abstract available


  80. ACHARJEE S, Teo KK, Jacobs AK, Hartigan PM, et al
    Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial.
    Am Heart J. 2016;173:108-17.
    PubMed     Text format     Abstract available


  81. BRIGUORI C, Visconti G, Donahue M, De Micco F, et al
    RenalGuard system in high-risk patients for contrast-induced acute kidney injury.
    Am Heart J. 2016;173:67-76.
    PubMed     Text format     Abstract available


    February 2016
  82. THIELE H, Desch S, Piek JJ, Stepinska J, et al
    Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial.
    Am Heart J. 2016;172:160-9.
    PubMed     Text format     Abstract available


  83. CALAIS F, Lagerqvist B, Leppert J, James SK, et al
    Thrombus aspiration in patients with large anterior myocardial infarction: A Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia trial substudy.
    Am Heart J. 2016;172:129-34.
    PubMed     Text format     Abstract available


  84. LIU Y, Chen JY, Huo Y, Ge JB, et al
    Aggressive hydraTion in patients with ST-Elevation Myocardial infarction undergoing Primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEM
    Am Heart J. 2016;172:88-95.
    PubMed     Text format     Abstract available


  85. SEBBEN JC, Pinto Ribeiro DR, Lopes RD, de Winter R, et al
    The role of diabetes mellitus in the composition of coronary thrombi in patients presenting with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Am Heart J. 2016;172:26-33.
    PubMed     Text format     Abstract available


  86. WANG TY, McCoy LA, Bhatt DL, Rao SV, et al
    Multivessel vs culprit-only percutaneous coronary intervention among patients 65 years or older with acute myocardial infarction.
    Am Heart J. 2016;172:9-18.
    PubMed     Text format     Abstract available


  87. DASARI TW, Hamilton S, Chen AY, Wang TY, et al
    Non-eligibility for reperfusion therapy in patients presenting with ST-segment elevation myocardial infarction: Contemporary insights from the National Cardiovascular Data Registry (NCDR).
    Am Heart J. 2016;172:1-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diagnostic Imaging is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: